Biochemical outcome in metastatic prostate cancer patients following prostate-directed radiotherapy

CONCLUSION: Prostate-directed RT improved BPFS and OS in mPCa patients, particularly in those with low volume and hormonal-sensitive disease.TRIAL REGISTRATION: This trial is registered on (27/4/2023), retrospectively registered with pactr.samrc.ac.za, PACTR202305854600529, URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=25510.PMID:38566761 | PMC:PMC10984844 | DOI:10.3332/ecancer.2024.1686

https://pubmed.ncbi.nlm.nih.gov/38566761/?utm_source=no_user_agent&utm_medium=rs...

Source: Ecancermedicalscience - April 3, 2024 Category: Cancer & Oncology Authors: Heba Maged Ayoub Fifi Mostafa Elsayed Maha Lotfy Zamzam Ihab Mohamed Hassanin Eman Essam Elsemary Source Type: research